Загрузка...

Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis

BACKGROUND: Non‐absorbable disaccharides (lactulose and lactitol) are recommended as first‐line treatment for hepatic encephalopathy. The previous (second) version of this review included 10 randomised clinical trials (RCTs) evaluating non‐absorbable disaccharides versus placebo/no intervention and...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cochrane Database Syst Rev
Главные авторы: Gluud, Lise Lotte, Vilstrup, Hendrik, Morgan, Marsha Y
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Ltd 2016
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004252/
https://ncbi.nlm.nih.gov/pubmed/27153247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003044.pub4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!